-
f
- Farydak® (Panobinostat)
Farydak® is a histone deacetylase inhibitor that is administered in combination with Velcade® (bortezomib) and dexamethasone. It is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including Velcade and an immunomodulatory agent. This(...) - Fast Track designation
Status assigned by the Food and Drug Administration (FDA) to a drug or product in clinical trials signifying that the FDA will facilitate and expedite the development and review of the application for the approval of the new drug. Fast track status is usually reserved for drugs that are(...) - Febrile neutropenia
Presence of a low neutrophil count in the blood that is associated with fever; may indicate the presence of infection (that may be serious or life-threatening).
- Fibroblast growth factor 2 (FGF-2)
Growth factor that promotes angiogenesis (the growth of new blood vessels); also known as basic fibroblast growth factor (bFGF).
- Filgrastim
A type of growth factor that stimulates the growth of white cells in the bone marrow; also known as G-CSF (granulocyte colony stimulating factor) or Neupogen™.
- Fluorescence in situ hybridization (FISH)
Laboratory technique used to measure the number of copies of a specific DNA segment in a cell and the structure of chromosomes.
- Fluoroscope
Type of X-ray that allows viewing of bone.
- Formulation
The preparation of a drug.
- Free light chain (FLC)
Short protein (immunoglobulin light chain) that is produced by myeloma cells and found in the blood.
- Frontline therapy
Initial treatment given to a newly diagnosed patient (also known as induction therapy, first-line therapy, or frontline treatment).
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties.
Need help? Chat now
The information provided by our AI chatbot is for general informational purposes only and
does not constitute medical advice. For any health-related questions, you should seek
professional medical advice.
By using our AI chatbot, you agree to let us store your messages.
For further details, see our privacy policy.
The Patient Navigation Center team can provide further detailed information. They're available at 1-888-841-6673, Monday-Friday, 9 AM-7 PM ET. You can also use the PNC contact web form.